Highlights

  • CONNEQT Health (ASX:CQT) develops cardiovascular monitoring devices and digital health solutions.
  • The CONNEQT Pulse combines blood pressure readings with additional vascular measurements.
  • The company is expanding consumer, enterprise and software opportunities.
  • Device adoption, subscriptions and funding remain key areas to monitor.

CONNEQT Health Limited (ASX:CQT) is an Australian cardiovascular technology company focused on developing connected health solutions. Formerly known as CardieX, the company uses its SphygmoCor technology platform to provide advanced cardiovascular measurements through connected devices. This article examines how CONNEQT is expanding beyond traditional blood pressure monitoring.

Cardiovascular Monitoring Technology

The CONNEQT Pulse device combines conventional blood pressure measurements with additional cardiovascular indicators, including central aortic pressure and arterial stiffness measurements.

The company’s technology is based on SphygmoCor, a platform used in cardiovascular research and clinical applications. CONNEQT aims to use these measurements to provide broader insights into cardiovascular health compared with standard blood pressure readings alone.

Consumer and Enterprise Expansion

CONNEQT has developed a consumer health model combining hardware, software and digital services. The company has also expanded its enterprise offering through healthcare subscriptions and clinical applications.

The combination of device sales, software services and recurring digital offerings forms part of the company’s strategy to build a broader healthcare technology platform.

Software Platform Development

Beyond devices, CONNEQT is developing connected software capabilities through its digital health platform. Software integration is intended to support data management, monitoring and potential remote healthcare applications.

The transition from device sales towards recurring digital services is an important part of the company’s longer-term strategy.

Funding and Future Considerations

CONNEQT remains in a development and commercial expansion phase requiring Investment in technology, market development and customer acquisition.

Future progress depends on increasing device adoption, expanding subscription-based Revenue and managing financial resources while scaling operations.

Key Insights

CONNEQT Health is building a cardiovascular technology platform that combines advanced measurements with connected healthcare services. The company’s future progress depends on converting its technology capabilities into broader adoption across consumer and healthcare markets.